Literature DB >> 14566064

Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases.

Siiri E Iismaa1, Sara Holman, Merridee A Wouters, Laszlo Lorand, Robert M Graham, Ahsan Husain.   

Abstract

Covalent posttranslational protein modifications by eukaryotic transglutaminases proceed by a kinetic pathway of acylation and deacylation. Ammonia is released as the acylenzyme is formed, whereas the cross-linked product is released later in the deacylation step. Superposition of the active sites of transglutaminase type 2 (TG2) and the structurally related cysteine protease, papain, indicates that in the formation of tetrahedral intermediates, the backbone nitrogen of the catalytic Cys-277 and the N1 nitrogen of Trp-241 of TG2 could contribute to transition-state stabilization. The importance of this Trp-241 side chain was demonstrated by examining the kinetics of dansylcadaverine incorporation into a model peptide. Although substitution of the Trp-241 side chain with Ala or Gly had only a small effect on the Michaelis constant Km (1.5-fold increase), it caused a >300-fold lowering of the catalytic rate constant kcat. The wild-type and mutant TG2-catalyzed release of ammonia showed kinetics similar to the kinetics for the formation of cross-linked product, indicating that transition-state stabilization in the acylation step was rate-limiting. In papain, a Gln residue is at the position of TG2-Trp-241. The conservation of Trp-241 in all eukaryotic transglutaminases and the finding that W241Q-TG2 had a much lower kcat than wild-type enzyme suggest evolutionary specialization in the use of the indole group. This notion is further supported by the observation that transition-state-stabilizing side chains of Tyr and His that operate in some serine and metalloproteases only partially substituted for Trp.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14566064      PMCID: PMC240670          DOI: 10.1073/pnas.1635052100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Structure of neurolysin reveals a deep channel that limits substrate access.

Authors:  C K Brown; K Madauss; W Lian; M R Beck; W D Tolbert; D W Rodgers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

2.  The Cationminus signpi Interaction.

Authors:  Jennifer C. Ma; Dennis A. Dougherty
Journal:  Chem Rev       Date:  1997-08-05       Impact factor: 60.622

3.  A photometric assay for blood coagulation factor XIII.

Authors:  K Fickenscher; A Aab; W Stüber
Journal:  Thromb Haemost       Date:  1991-05-06       Impact factor: 5.249

4.  GTP binding and signaling by Gh/transglutaminase II involves distinct residues in a unique GTP-binding pocket.

Authors:  S E Iismaa; M J Wu; N Nanda; W B Church; R M Graham
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

5.  Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).

Authors:  J J Gorman; J E Folk
Journal:  J Biol Chem       Date:  1980-01-25       Impact factor: 5.157

6.  Transamidase kinetics. Amide formation in the enzymic reactions of thiol esters with amines.

Authors:  P Stenberg; C G Curtis; D Wing; Y S Tong; R B Credo; A Gray; L Lorand
Journal:  Biochem J       Date:  1975-04       Impact factor: 3.857

7.  Three-dimensional structure of the human transglutaminase 3 enzyme: binding of calcium ions changes structure for activation.

Authors:  Bijan Ahvazi; Hee Chul Kim; Sun-Ho Kee; Zoltan Nemes; Peter M Steinert
Journal:  EMBO J       Date:  2002-05-01       Impact factor: 11.598

8.  Crystal structure of red sea bream transglutaminase.

Authors:  K Noguchi; K Ishikawa; T Ohtsuka; N Nio; E Suzuki
Journal:  J Biol Chem       Date:  2000-11-15       Impact factor: 5.157

9.  Origin of the different pH activity profile in two homologous ketosteroid isomerases.

Authors:  Young Sung Yun; Tae-Hee Lee; Gyu Hyun Nam; Do Soo Jang; Sejeong Shin; Byung-Ha Oh; Kwan Yong Choi
Journal:  J Biol Chem       Date:  2003-05-06       Impact factor: 5.157

10.  Role of histidine 373 in the catalytic activity of coagulation factor XIII.

Authors:  R Micanovic; R Procyk; W Lin; G R Matsueda
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

View more
  11 in total

Review 1.  γ-Glutamylamines and neurodegenerative diseases.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

2.  Mechanism of allosteric regulation of transglutaminase 2 by GTP.

Authors:  Gillian E Begg; Lyle Carrington; Philippa H Stokes; Jacqueline M Matthews; Merridee A Wouters; Ahsan Husain; Laszlo Lorand; Siiri E Iismaa; Robert M Graham
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-18       Impact factor: 11.205

Review 3.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

4.  Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models.

Authors:  Bo Mi Ku; Se-Jin Kim; Nayeon Kim; Dongwan Hong; Yong-Bock Choi; Seon-Hyeong Lee; Young-Dae Gong; Soo-Youl Kim
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-08       Impact factor: 4.553

5.  Tissue transglutaminase activity in human gastric mucosa according to Helicobacter pylori infection.

Authors:  Maria Pina Dore; Giovanni Mario Pes; Alessandra Errigo; Alessandra Manca; Giuseppe Realdi
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

6.  Opposing effects of two tissue transglutaminase protein isoforms in neuroblastoma cell differentiation.

Authors:  Andrew E L Tee; Glenn M Marshall; Pei Y Liu; Ning Xu; Michelle Haber; Murray D Norris; Siiri E Iismaa; Tao Liu
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

Review 7.  Transglutaminase is a tumor cell and cancer stem cell survival factor.

Authors:  Richard L Eckert; Matthew L Fisher; Dan Grun; Gautam Adhikary; Wen Xu; Candace Kerr
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

8.  Transglutaminase activation in neurodegenerative diseases.

Authors:  Thomas M Jeitner; Nancy A Muma; Kevin P Battaile; Arthur Jl Cooper
Journal:  Future Neurol       Date:  2009-07-01

Review 9.  Biocatalysis by Transglutaminases: A Review of Biotechnological Applications.

Authors:  Maria Pia Savoca; Elisa Tonoli; Adeola G Atobatele; Elisabetta A M Verderio
Journal:  Micromachines (Basel)       Date:  2018-10-31       Impact factor: 2.891

10.  Transglutaminase 2 undergoes a large conformational change upon activation.

Authors:  Daniel M Pinkas; Pavel Strop; Axel T Brunger; Chaitan Khosla
Journal:  PLoS Biol       Date:  2007-12       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.